Esteemed Peer Perspective Board helps chart course for Healio’s Women in Oncology

Women in Oncology, a first-of-its kind effort from Healio, will inform, inspire, engage and empower female professionals with guidance from those who have exceled in their professional careers, mentored younger doctors, and led full and rewarding personal lives.

Healio’s Women in Oncology will advance the work of women in the field of oncology and provide essential insights for overcoming their unique challenges.

Our Peer Perspective Board, under the leadership of Consulting Medical Editor, Shikha Jain, MD, FACP, will guide us along this journey, but we will also rely on feedback from readers through our website at https://www.healio.com/news/hematology-oncology/resources/women-in-oncology/home and Twitter feed, @WomenInOnc, to help keep us on course. Email the editor at WomenInOncology@healio.com if you would like to participate.

Meet our esteemed Peer Perspective Board here:

Jain is an associate professor of medicine with tenure in the division of hematology, oncology and cell therapy, and associate director of oncology communication and digital innovation at the University of Illinois Cancer Center.

Charu Aggarwal, MD, MPH, is the Leslye M. Heisler associate professor of lung cancer excellence in the University of Pennsylvania’s division of hematology/oncology.

Jubilee Brown, MD, is a professor and the division director of gynecologic oncology at the Levine Cancer Institute and Hall Gynecologic Oncology Center.

Barbara Burtness, MD, is a professor of medical oncology at Yale School of Medicine. She is the co-leader of developmental therapeutics and the disease aligned research team leader of the head and neck cancers program at the Yale Cancer Center.

Anees B. Chagpar, MD, MSc, MPH, MA, MBA, FRCS(C), FACS, is a professor in Yale University School of Medicine’s department of surgery.

Fumiko Chino, MD, is a radiation oncologist at Memorial Sloan Kettering Cancer Center.

Suzanne Cole, MD, FACP, a hematologist and medical oncologist, is the medical director of UT Southwestern Simmons Cancer Center in Richardson/Plano, Texas, where she is also an assistant professor in the division of hematology and oncology.

Amy Comander, MD, DipABLM, is director of breast oncology and survivorship at the Massachusetts General Hospital Cancer Center in Waltham and at Newton-Wellesley, and co-medical director of the Massachusetts General Hospital Cancer Center in Waltham. She also is an instructor in medicine at Harvard Medical School.

Nancy Davidson, MD, is the president and executive director of the Seattle Cancer Care Alliance. She leads Fred Hutchinson Cancer Research Center’s Clinical Research division as senior vice president, where she is a professor and was also named Raisbeck Endowed Chair for Collaborative Cancer Research. Davidson is also a professor and head of the division of medical oncology in the University of Washington’s department of medicine.

Narjust Florez, MD, is an associate director of the cancer care equity program and thoracic medical oncologist at Lowe Center for Thoracic Oncology at Dana-Farber Cancer Institute, and member of the faculty at Harvard Medical School.

Stephanie L. Graff, MD, FACP, directs HCA Midwest Health’s breast cancer and clinical research programs. She is also the associate director of breast cancer clinical research at the Sarah Cannon Research Institute and leads breast cancer clinical programming at the Sarah Cannon Cancer Network.

Reshma Jagsi, MD, DPhil, FASCO, FASTRO, is Lawrence W. Davis professor and chair of the department of radiation oncology at Emory University School of Medicine.

Edward S. Kim, MD, MBA, is vice physician-in-chief and professor in the department of medical oncology and therapeutics research a City of Hope National Medical Center.

Priya U. Kumthekar, MD, is an associate professor of neurology and hematology/oncology at the Northwestern University’s Feinberg College of Medicine.

Pamela Kunz, MD, leads the gastrointestinal cancers program and directs gastrointestinal medical oncology at Yale School of Medicine and Yale Cancer Center, where she is also an associate professor of medicine/oncology.

Jose P. Leone, MD, is director of the program for breast cancer in men at Dana-Farber Cancer Institute.

Merry-Jennifer Markham, MD, FACP, FASCO, is the interim chief and professor of the University of Florida’s division of hematology and oncology. She is also the associate director for medical affairs at the University of Florida Health Cancer Center.

Marcela Maus, MD, PhD, directs the cellular immunotherapy program at Massachusetts General Hospital, where she is also an attending physician of hematology/oncology. She is an assistant professor of medicine at Harvard Medical School. She is an associate member of the Broad Institute of MIT and Harvard as well as the Ragon Institute of MGH, MIT and Harvard.

Debra Patt, MD, PhD, MBA, FASCO, chairs the Texas Medical Association’s council on legislation. She is also the executive vice president of policy and strategic initiatives at Texas Oncology and medical director of analytics at Mckesson Specialty Health.

Rachna T. Shroff, MD, MS, FASCO, is interim chief of the division of hematology/oncology, associate dean of clinical and translational research, and associate director of clinical investigations at University of Arizona Cancer Center.

Cardinale B. Smith, MD, PhD, is an associate professor of medicine in the Icahn School of Medicine at Mount Sinai and chief quality officer of cancer services in the Mount Sinai Health System.

Eleonora Teplinsky, MD, is head of the department of breast and gynecologic medical oncology at The Valley Hospital in New Jersey.

Carrie A. Thompson, MD, MS, is the residency program director and associate chair of the Mayo Clinic College of Medicine and Science’s Department of Medicine, where she also is an associate professor. She is a consultant within the division of hematology.

Sara M. Tolaney, MD, MPH, is the associate director of the Susan F. Smith Center for Women’s Cancers and an assistant professor of medicine at Harvard Medical School. She also directs breast oncology clinical trials and breast immunotherapy clinical research in the breast oncology program at the Dana-Farber Cancer Institute, where she is also a senior physician.

Ishwaria Subbiah, MD, is executive director for cancer care equity and professional wellness at Sarah Cannon Research Institute.

Ashley Sumrall, MD, FACP, is the section chief of Neuro-Oncology at Levine Cancer Institute in Charlotte, N.C. She is an associate professor of medicine and serves as faculty for the internal medicine residency program and the hematology/oncology fellowship program at Atrium Health-Carolinas Medical Center, as well as clinical assistant professor of medicine in affiliation with University of North Carolina at Chapel Hill Charlotte campus. Sumrall also serves on a number of ASCO’s committees and panels.

Neeta K. Venepalli, MD, MBA, FACP, is an associate professor at the University of Illinois’ division of hematology oncology within the department of medicine. She is the associate chief medical officer at the University of Illinois Hospital and chairs the university cancer center’s data safety monitoring committee.

Marisa C. Weiss, MD, is the founder and chief medical officer of Breastcancer.org and the director of breast radiation oncology at Lankenau Medical Center in Wynnewood, Pennsylvania.